Tyrosine Protein Kinase SYK Market Trends, Size, Competitive Analysis and Forecast 2021-2027

The global tyrosine protein kinase SYK market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Tyrosine protein kinase SYK is also known as spleen tyrosine kinase (SYK). It is a non-receptor cytoplasmic enzyme and is primarily expressed in cells of hematopoietic lineage. It contains two adjacent SH2 domains that bind to immunoreceptor tyrosine-based activation motifs (ITAMs) to activate the enzyme. The major factor driving the growth of the market is the rising prevalence of arthritis across the globe.

According to Arthritis Org, in 2020, over 54 million adults had doctor-diagnosed arthritis with more than 1 in 4 US adults. Additionally, almost 300,000 children had arthritis in 2020. Furthermore, this disease affects more adults younger than age 65 with more than 1 in 3 people (both men and women), aged 18 to 64, having symptoms consistent with arthritis. Hence, the rising prevalence of arthritis is driving the demand for tyrosine protein kinase SYK for treatment which in turn is driving the growth of the market. Moreover, Fostamatinib was the first oral SYK inhibitor used for the treatment of rheumatoid arthritis and lymphoid malignancies.

To Request a Sample of our Report on Tyrosine Protein Kinase SYK Market: https://www.omrglobal.com/request-sample/tyrosine-protein-kinase-syk-market

Some major players in the market include Celgene Corp., Gilead Sciences Inc., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in July 2021, Kronos Bio announced that the FDA cleared its IND for next-generation spleen tyrosine kinase (SYK) inhibitor lanraplenib (LANRA) for relapsed/refractory and newly diagnosed acute myeloid leukemia (AML).

Market Coverage

• The market number available for - 2020-2027

• Base year- 2020

• Forecast period- 2021-2027

Segment Covered-

• By Type

• By Application

Regions Covered-

· North America

· Europe

· Asia-Pacific

· Rest of the World

Competitive Landscape- Celgene Corp., Clevexel Pharma SAS, Gilead Sciences Inc., GlaxoSmithKline Plc, among others.

(Get 15% Discount on Buying this Report)

A full Report of Tyrosine Protein Kinase SYK Market is Available @ https://www.omrglobal.com/industry-reports/tyrosine-protein-kinase-syk-market

Global Tyrosine Protein Kinase SYK Market Report Segment

By Type

• HMPL-523

• C-13

• CVXL-0074

• ASN-002

• FF-10102

• Others

By Application

• Anaphylactic Shock

• Arthritis

• Fallopian Tube Cancer

• Lupus Naphritis

• Other

Global Tyrosine Protein Kinase SYK Market Report by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

· Latin America

· Middle East & Africa

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.